Porównaj najlepszych lekarzy Chemioterapia w przypadku chłoniaka i ceny w Izrael. Tutaj znajdziesz najlepsze dopasowanie.
Dobierzemy najlepszych lekarzy w zależności od Twoich potrzeb i budżetu.
Redaktor medyczny Fahad Mawlood
Redaktor medyczny, Data ScientistNajlepsi lekarze
16
Izrael
Opinie
14000+
Od prawdziwych pacjentów
Porównaj ceny Chemioterapia w przypadku chłoniaka w najlepszych krajach
Kliknij kraj, aby zobaczyć najlepszych lekarzy i ceny
Uzyskaj darmowy, spersonalizowany plan leczenia i wybierz najlepszą opcję. Bez zobowiązań · Bez opłat za nasze usługi
Pokaż najpierw:
Dr Ram Ron specjalizuje się w chemioterapii chłoniaków w Centrum Medycznym Sourasky (Ichilov), wnosząc rozległą wiedzę w zakresie skomplikowanych przypadków.
Dr Ron Ram wykonał kilkaset przeszczepów komórek macierzystych, co świadczy o jego dużym doświadczeniu w leczeniu chłoniaków w Centrum Medycznym Sourasky.
Kierownik Oddziału Onkohematologii Dziecięcej w Szpitalu Dziecięcym im. Dany Dwek – dr El Hasid specjalizuje się w przeszczepach szpiku kostnego i krwi pępowinowej. Przeprowadził ponad 300 procedur.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.
She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.
She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.
She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.
Specjalizuje się w przeszczepianiu szpiku kostnego – dr Shapira wnosi ukierunkowaną wiedzę do chemioterapii chłoniaków w Centrum Medycznym Sourasky.
31 lat doświadczenia w onkohematologii – dr Aviv specjalizuje się w chemioterapii chłoniaków w Centrum Medycznym Sourasky (Ichilov).
Dr Dror Levin jest wiodącym ekspertem w dziedzinie pediatrycznych chorób krwi i nowotworów kości; kieruje oddziałem hematologii i onkologii w Centrum Medycznym Sourasky.
Dr Herishanu Yair zdobył wiele nagród za swoje badania nad przewlekłą białaczką limfocytową oraz w dziedzinie hematologii w Centrum Medycznym Sourasky.
Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.
Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.
He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.
He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).
Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.
She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.
Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.
Kierowniczka Oddziału Hematologii w Centrum Medycznym Hadassah – profesor Ben-yehuda była pionierką terapii genowej i przeszczepów szpiku kostnego w leczeniu chłoniaków.
Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.
She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.
Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.
Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.
He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.
Wybór kliniki za granicą może być trudny. Zespół Bookimed pomógł już ponad 800 tysiącom pacjentów i rozumie wasze obawy. Wiemy, jak znaleźć wiarygodnych lekarzy, opcje z najlepszym stosunkiem ceny do jakości oraz rozwiązania nawet dla skomplikowanych przypadków. Jesteśmy gotowi wspierać was na każdym etapie tej podróży.
Yan Matsiievskyi
Kierownik zespołu lekarzy-koordynatorów
Ponad 4300+ przebytych ścieżek pacjentów z naszym wsparciem
3 lat doświadczenia w Bookimed
142 pacjentów z Israel znalazło swojego lekarza przez nas w tym miesiącu
2-minutowy test
Powiedz nam o swoim celu, budżecie i terminie
Dopasowanie przez człowieka + AI
Nasz algorytm znajduje dopasowania, koordynator weryfikuje trafność
Twoje propozycje gotowe
Porównaj ceny, pakiety, terminy. Porozmawiaj z koordynatorem
Przytłacza Cię wybór?
Prowadzi Twój proces leczenia
Wykształceni medycznie osobisti koordynatorzy
| Miejsce | Lekarz | doświadczenie | Odpowiedni dla | Czym się wyróżniają | Klinika i lokalizacja | Konsultacja |
|---|---|---|---|---|---|---|
| #1 | 24 lat doświadczenia | Złożone przypadki chłoniaka | Specjalizuje się w złożonej chemioterapii chłoniaków i posiada w tym zakresie rozległe doświadczenie. Odbył staż specjalizacyjny (fellowship) w Centrum Ronalda O. Perelmana i Claudii Cohen. | Izrael | Cena na zapytanie | |
| #2 | 24 lat doświadczenia | Przeszczepy komórek macierzystych | Specjalizuje się w przeszczepach komórek macierzystych i ma bogate doświadczenie. Opublikował ponad 30 artykułów naukowych oraz wniósł wkład w powstanie podręcznika medycznego. | Izrael | Cena na zapytanie | |
| #3 | 38 lat doświadczenia | Leczenie chłoniaka u dzieci | Czołowy onkolog, koncentrujący się wyłącznie na przypadkach pediatrycznych, z ponad 300 przeprowadzonymi przeszczepami. Kieruje specjalistycznym oddziałem w jednym z najlepszych szpitali dziecięcych w Izraelu. | Izrael | Cena na zapytanie | |
| #4 | 36 lat doświadczenia | Przeszczep szpiku kostnego | Specjalizuje się wyłącznie w transplantacji szpiku kostnego – starszy lekarz w renomowanym programie Hadassah. Biegle posługuje się językiem angielskim i hebrajskim, co jest kluczowe dla pacjentów międzynarodowych. | Izrael | Cena na zapytanie | |
| #5 | 34 lat doświadczenia | Chemioterapia chłoniaka | Specjalizuje się w nowotworach krwi, posiadając trzy dekady doświadczenia. Zapewnia spersonalizowane plany leczenia w najlepszym ośrodku medycznym w Izraelu. | Izrael | Cena na zapytanie | |
| #6 | 41 lat doświadczenia | Chłoniaki i mięsaki dziecięce | Specjalizuje się w dziecięcych chorobach krwi i nowotworach kości – kieruje wiodącym oddziałem hematologii i onkologii. Szkolenie odbył w czołowych placówkach, w tym w Instytucie Ortopedycznym Rizzoli. | Izrael | Cena na zapytanie | |
| #7 | 24 lat doświadczenia | Przewlekła białaczka limfocytowa | Wielokrotnie nagradzany hematolog, specjalizujący się w przewlekłej białaczce limfocytowej. Uznany za doskonałość kliniczną oraz wkład w badania naukowe w dziedzinie hematologii. | Izrael | Cena na zapytanie | |
| #8 | 34 lat doświadczenia | Zaawansowane przypadki chłoniaka | Pionier w dziedzinie terapii genowej i przeszczepów szpiku kostnego w leczeniu chłoniaka. Pierwsza kobieta Dziekan Szkoły Medycznej Hadassah, ze szkoleniem zdobytym w Sloan-Kettering. | Izrael | Cena na zapytanie |
Israel features world-renowned hematology experts who hold board certifications in internal medicine and medical oncology. These specialists often complete elite fellowships at institutions like Stanford University or Memorial Sloan-Kettering. Many lead dedicated bone marrow transplant units at JCI-accredited centers in Tel Aviv and Jerusalem.
Bookimed Expert Insight: Data shows a high concentration of expertise at Sourasky Medical Center, where doctors like Dr. Fredi Aviv bring 30+ years of experience. At Sheba Medical Center, Professor Arnon Nagler is a global pioneer who founded the country’s first public cord blood bank. This high level of specialization in both chemotherapy and transplantation provides patients with comprehensive care under one roof.
Patient Consensus: Patients note that the hospital infrastructure and access to multidisciplinary teams are just as vital as the doctor's reputation. They appreciate that oncology teams in major urban centers speak English fluently, making the complex process much easier. Many suggest getting multiple opinions before starting protocols to feel confident in the chosen treatment plan.
When choosing a lymphoma chemotherapy doctor in Israel, focus on hematologists with international fellowship training and board certification in medical oncology. Top specialists often hold leadership roles in bone marrow transplant departments and maintain memberships in the American Society of Hematology to stay current with global protocols.
Bookimed Expert Insight: Data shows that choosing a doctor who also heads a specialized department, such as Dr. Ron Ram or Dr. Ronit El Hasid, provides a distinct advantage. These leaders often manage both chemotherapy and stem cell transplant programs, ensuring a seamless transition if initial treatments require more intensive cell therapy later.
Patient Consensus: Patients note that clear communication about side effects significantly reduces their anxiety during the infusion process. They often feel more confident when their hematologist provides a tailored plan that includes consistent post-treatment follow-up and access to supportive hospital staff.
Israel offers top-tier pediatric lymphoma specialists at world-class oncology centers. These experts specialize in advanced therapies and bone marrow transplants for children. Leading doctors like Dr. Ronit El Hasid and Dr. Dror Levin provide specialized care for young patients with blood disorders.
Bookimed Expert Insight: Data shows a concentration of elite pediatric oncology expertise at JCI-accredited facilities in Tel Aviv. For example, Dr. Ronit El Hasid and Dr. Dror Levin both practice at Sourasky Medical Center. This allows families to access multiple specialists for complex lymphoma cases within a single high-ranking hospital.
Patient Consensus: Parents describe the medical teams as precise and notice fewer side effects during chemotherapy. Many families feel relieved by the short wait times for starting personalized treatment protocols. They appreciate that major centers provide English-fluent staff to help navigate the care process smoothly.
Israel offers advanced lymphoma treatments through world-recognized hematologists specializing in CAR T-cell therapy and molecular diagnostics. Leading specialists at JCI-accredited centers like Sheba and Sourasky (Ichilov) provide innovative cellular therapies. Most experts hold fellowships from top-tier US institutions like Stanford and Mayo Clinic.
Bookimed Expert Insight: Israeli hematology centers often develop in-house CAR-T protocols rather than relying only on commercial brands. At Sheba Medical Center, these internal laboratory capabilities can significantly reduce the cell preparation time. Patients benefit from localized manufacturing which may streamline the treatment timeline for aggressive lymphoma types.
Patient Consensus: Patients note that targeted therapies like ibrutinib are often more accessible than CAR T-cell programs. Many mention the importance of verifying eligibility for specific lymphoma subtypes before starting the travel process. Some patients feel more confident after getting a second opinion to validate their intensive treatment plans.
Finding and booking a top lymphoma chemotherapy specialist in Israel involves selecting board-certified hematologists at JCI-accredited centers like Sourasky, Sheba, or Hadassah. You can secure appointments with experts who hold fellowships from institutions like Stanford or Memorial Sloan Kettering via Bookimed coordination services.
Bookimed Expert Insight: Data shows that top Israeli hematologists often hold dual research-clinical roles at university hospitals. For example, Prof. Dina Ben-yehuda at Hadassah and Prof. Arnon Nagler Md at Sheba both lead major departments while maintaining active research in gene therapy. This combination ensures patients receive treatment protocols that incorporate the newest scientific findings before they become standard elsewhere.
Patient Consensus: Patients emphasize the importance of having pathology reports ready in English to speed up the matching process with specialists. Many note that choosing university hospitals provides a multidisciplinary team approach that feels more thorough than private clinics. They often feel relieved by how quickly international coordinators can organize the first consultation once records are submitted.